In-Stock

As seen on

* These therapies are not FDA approved for the treatment, cure, or prevention of any disease. Information provided is for educational purposes only. Individual results may vary, and treatments should be discussed with a licensed clinician to determine appropriateness.

Daily Oral

Daily Nasal

Compounded GLP-1/GIP (Contains Tirzepatide)

1 Month Supply Of Injections for weight loss with dual power and greater results

$

359

3 Month Supply

6 Month Supply

12 Month Supply

Buy now

Key Benefits

A next-generation compounded GLP-1/GIP injection with tirzepatide, combining dual pathways for appetite regulation and metabolic improvement, designed to support significant progress in weight care and health goals.

How It Works

Compounded GLP-1/GIP (Tirzepatide) is a once-weekly injectable therapy that mimics dual incretin hormones, potentially offering stronger support for appetite regulation and metabolic balance than GLP-1 alone.

Why It's Unique

This dual-acting option combines two pathways in one medication, giving patients a next-generation therapy under professional guidance in a convenient, accessible setting.

The Fridays Difference

Fridays’ weight loss program provides access to compounded GLP-1 and GLP-1/GIP therapies with licensed clinician oversight. Care is paired with transparent pricing, telehealth convenience, and ongoing support—helping you explore safe, science-driven options for reaching your health goals in a way that fits your lifestyle.

support@joinfridays.com

Contáctanos

ayuda@joinfridays.com

Download our app

Fridays' whitepapers:

NAD+ Whitepaper Sermorelin Whitepaper

The assessment available on the Fridays website does not create a doctor–patient relationship. Clinical services are provided by OpenLoop Health and other networks of U.S.-licensed clinicians who determine eligibility for GLP-1 treatment based on medical history and assessment responses. Providers retain full discretion to prescribe or decline compounded GLP-1 medications. Compounded medications offered through Fridays are produced in FDA-registered facilities but are not FDA-approved and have not been evaluated by the FDA for safety, efficacy, or quality. Results may vary and depend on individual adherence, provider guidance, and lifestyle changes. Fridays does not manufacture compounded medications, and product appearance may differ from website images. Fridays partners with certified U.S. pharmacies to ensure high standards of safety and quality. Medication costs are included in the Fridays program. Zepbound® is FDA-approved for chronic weight management; Ozempic® is FDA-approved for type 2 diabetes treatment but may be prescribed off-label for weight management. All trademarks are the property of their respective owners. Unless otherwise noted, results reflect Fridays patient experiences rather than public clinical studies.

17322 Murphy Ave, Irvine, CA 92614 (484) 715 9081